Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)
China
· Delayed Price · Currency is CNY 5.14
+0.08 (1.58%)
May 23, 2025, 1:45 PM CST
SHE:000908 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 416.03 | 645.32 | 822.56 | 771.86 | 866.83 | Upgrade
|
| Other Revenue | - | 11.58 | 18.1 | 39.33 | 11.09 | Upgrade
|
| Revenue | 416.03 | 656.89 | 840.66 | 811.18 | 877.92 | Upgrade
|
| Revenue Growth (YoY) | -36.67% | -21.86% | 3.63% | -7.60% | -34.68% | Upgrade
|
| Cost of Revenue | 154.76 | 197.92 | 205.82 | 323.64 | 330.55 | Upgrade
|
| Gross Profit | 261.27 | 458.97 | 634.83 | 487.55 | 547.37 | Upgrade
|
| Selling, General & Admin | 249.73 | 502.89 | 591.81 | 711.34 | 832.57 | Upgrade
|
| Research & Development | 13.02 | 52.51 | 35.64 | 38.63 | 252.88 | Upgrade
|
| Other Operating Expenses | 1.83 | 10.77 | 11.98 | 27.36 | 16.37 | Upgrade
|
| Operating Expenses | 264.57 | 563.35 | 654.27 | 797.37 | 1,246 | Upgrade
|
| Operating Income | -3.3 | -104.38 | -19.44 | -309.83 | -698.83 | Upgrade
|
| Interest Expense | - | -41.89 | -52.23 | -85.85 | -105.92 | Upgrade
|
| Interest & Investment Income | 264.31 | 5.3 | 1.12 | 249.89 | 224.55 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.04 | 0.15 | -0.05 | 0.65 | Upgrade
|
| Other Non Operating Income (Expenses) | -72.67 | 0.51 | 1.85 | -19.08 | -7.78 | Upgrade
|
| EBT Excluding Unusual Items | 188.34 | -140.42 | -68.54 | -164.92 | -587.32 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -360.83 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.25 | 24.81 | 13.82 | -3.79 | -180.93 | Upgrade
|
| Gain (Loss) on Sale of Assets | -3.36 | 7.56 | 9.8 | 55.89 | -0.18 | Upgrade
|
| Asset Writedown | -19.2 | -83.76 | -39.56 | -42.79 | -19.24 | Upgrade
|
| Legal Settlements | - | -6.12 | -15.33 | -13.72 | - | Upgrade
|
| Other Unusual Items | - | 24.27 | 14.17 | 13.89 | -3.41 | Upgrade
|
| Pretax Income | 164.53 | -173.67 | -85.63 | -155.44 | -1,152 | Upgrade
|
| Income Tax Expense | 5.08 | 32.84 | 9.62 | 46.2 | 3.39 | Upgrade
|
| Earnings From Continuing Operations | 159.45 | -206.5 | -95.25 | -201.64 | -1,155 | Upgrade
|
| Minority Interest in Earnings | -7.14 | -8.64 | -27.31 | 37.98 | 86.79 | Upgrade
|
| Net Income | 152.3 | -215.14 | -122.56 | -163.66 | -1,069 | Upgrade
|
| Net Income to Common | 152.3 | -215.14 | -122.56 | -163.66 | -1,069 | Upgrade
|
| Shares Outstanding (Basic) | 880 | 880 | 880 | 880 | 883 | Upgrade
|
| Shares Outstanding (Diluted) | 880 | 880 | 880 | 880 | 883 | Upgrade
|
| Shares Change (YoY) | -0.01% | 0.01% | -0.01% | -0.36% | 0.03% | Upgrade
|
| EPS (Basic) | 0.17 | -0.24 | -0.14 | -0.19 | -1.21 | Upgrade
|
| EPS (Diluted) | 0.17 | -0.24 | -0.14 | -0.19 | -1.21 | Upgrade
|
| Free Cash Flow | -6.93 | 24.64 | 109.75 | 85.72 | -367.72 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | 0.03 | 0.13 | 0.10 | -0.42 | Upgrade
|
| Gross Margin | 62.80% | 69.87% | 75.52% | 60.10% | 62.35% | Upgrade
|
| Operating Margin | -0.79% | -15.89% | -2.31% | -38.19% | -79.60% | Upgrade
|
| Profit Margin | 36.61% | -32.75% | -14.58% | -20.18% | -121.71% | Upgrade
|
| Free Cash Flow Margin | -1.67% | 3.75% | 13.05% | 10.57% | -41.89% | Upgrade
|
| EBITDA | 23.04 | -65.85 | 32.24 | -212.35 | -617.37 | Upgrade
|
| EBITDA Margin | 5.54% | -10.02% | 3.83% | -26.18% | -70.32% | Upgrade
|
| D&A For EBITDA | 26.34 | 38.53 | 51.68 | 97.47 | 81.45 | Upgrade
|
| EBIT | -3.3 | -104.38 | -19.44 | -309.83 | -698.83 | Upgrade
|
| EBIT Margin | -0.79% | -15.89% | -2.31% | -38.19% | -79.60% | Upgrade
|
| Effective Tax Rate | 3.09% | - | - | - | - | Upgrade
|
| Revenue as Reported | - | 656.89 | 840.66 | 811.18 | 877.92 | Upgrade
|
| Advertising Expenses | - | 20.6 | 49.36 | 73.33 | 39.49 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.